PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
23171305-2	2012	In this study, heterogeneous kinetics of particulate syringaldehyde (SA), vanillic acid (VA), and coniferyl aldehyde (CA) with NO3 radicals is investigated with a mixed-phase relative rate method.	syringaldehyde	69-71	NBL1, DAN family BMP antagonist	Homo sapiens	127-130
23171305-4	2012	The reactive uptake coefficients of NO3 radicals on SA, VA, and CA particles are calculated to be 0.33, 0.31, and 0.28, respectively, according to the measured methoxyphenol loss ratios and the average NO3 concentrations.	syringaldehyde	52-54	NBL1, DAN family BMP antagonist	Homo sapiens	36-39
35429924-0	2022	A chalcone-syringaldehyde hybrid inhibits triple-negative breast cancer cell proliferation and migration by inhibiting CKAP2-mediated FAK and STAT3 phosphorylation.	syringaldehyde	11-25	cytoskeleton associated protein 2	Homo sapiens	119-124
23171305-5	2012	The effective rate constants for heterogeneous reactions of particulate SA, VA, and CA with NO3 radicals measured under experimental conditions are 5.7 x 10-12, 5.2 x 10-12, and 3.5 x 10-12 cm3 molecule-1 s-1, respectively.	syringaldehyde	72-74	NBL1, DAN family BMP antagonist	Homo sapiens	92-95
10787090-6	2000	However, in tyrosinase-mediated reactions controlled by nucleophilic addition, catechol enhanced the dehalogenation of most of the chlorophenols, whereas syringaldehyde had little effect.	syringaldehyde	154-168	tyrosinase	Homo sapiens	12-22
34246193-5	2021	By performing virtual screening with molecular docking, the data showed that syringaldehyde nicely interacted with glucagon-like peptide 1 receptor (GLP-1R), peroxisome proliferator-activated receptor (PPAR), dipeptidyl peptidase-IV (DPP-4), acetylcholine M2 receptor, and acetylcholinesterase.	syringaldehyde	77-91	glucagon-like peptide 1 receptor	Mus musculus	115-147
34246193-5	2021	By performing virtual screening with molecular docking, the data showed that syringaldehyde nicely interacted with glucagon-like peptide 1 receptor (GLP-1R), peroxisome proliferator-activated receptor (PPAR), dipeptidyl peptidase-IV (DPP-4), acetylcholine M2 receptor, and acetylcholinesterase.	syringaldehyde	77-91	glucagon-like peptide 1 receptor	Mus musculus	149-155
34246193-5	2021	By performing virtual screening with molecular docking, the data showed that syringaldehyde nicely interacted with glucagon-like peptide 1 receptor (GLP-1R), peroxisome proliferator-activated receptor (PPAR), dipeptidyl peptidase-IV (DPP-4), acetylcholine M2 receptor, and acetylcholinesterase.	syringaldehyde	77-91	peroxisome proliferator activated receptor alpha	Mus musculus	158-200
34246193-5	2021	By performing virtual screening with molecular docking, the data showed that syringaldehyde nicely interacted with glucagon-like peptide 1 receptor (GLP-1R), peroxisome proliferator-activated receptor (PPAR), dipeptidyl peptidase-IV (DPP-4), acetylcholine M2 receptor, and acetylcholinesterase.	syringaldehyde	77-91	peroxisome proliferator activated receptor alpha	Mus musculus	202-206
34246193-5	2021	By performing virtual screening with molecular docking, the data showed that syringaldehyde nicely interacted with glucagon-like peptide 1 receptor (GLP-1R), peroxisome proliferator-activated receptor (PPAR), dipeptidyl peptidase-IV (DPP-4), acetylcholine M2 receptor, and acetylcholinesterase.	syringaldehyde	77-91	dipeptidylpeptidase 4	Mus musculus	209-232
34246193-5	2021	By performing virtual screening with molecular docking, the data showed that syringaldehyde nicely interacted with glucagon-like peptide 1 receptor (GLP-1R), peroxisome proliferator-activated receptor (PPAR), dipeptidyl peptidase-IV (DPP-4), acetylcholine M2 receptor, and acetylcholinesterase.	syringaldehyde	77-91	dipeptidylpeptidase 4	Mus musculus	234-239
34246193-5	2021	By performing virtual screening with molecular docking, the data showed that syringaldehyde nicely interacted with glucagon-like peptide 1 receptor (GLP-1R), peroxisome proliferator-activated receptor (PPAR), dipeptidyl peptidase-IV (DPP-4), acetylcholine M2 receptor, and acetylcholinesterase.	syringaldehyde	77-91	acetylcholinesterase	Mus musculus	242-293
35429924-0	2022	A chalcone-syringaldehyde hybrid inhibits triple-negative breast cancer cell proliferation and migration by inhibiting CKAP2-mediated FAK and STAT3 phosphorylation.	syringaldehyde	11-25	protein tyrosine kinase 2	Homo sapiens	134-137
35429924-0	2022	A chalcone-syringaldehyde hybrid inhibits triple-negative breast cancer cell proliferation and migration by inhibiting CKAP2-mediated FAK and STAT3 phosphorylation.	syringaldehyde	11-25	signal transducer and activator of transcription 3	Homo sapiens	142-147
35429924-4	2022	PURPOSE: The present study aimed to synthesize a chalcone-syringaldehyde hybrid (CSH1) and explore its potential anti-TNBC effects and the underlying molecular mechanism.	syringaldehyde	58-72	chorionic somatomammotropin hormone 1	Homo sapiens	81-85
32291420-13	2020	Syringaldehyde treatment decreased nNOS, caspase-3, and NF-kappaB expressions immunohistochemically.	syringaldehyde	0-14	nitric oxide synthase, brain	Oryctolagus cuniculus	35-39
32291420-13	2020	Syringaldehyde treatment decreased nNOS, caspase-3, and NF-kappaB expressions immunohistochemically.	syringaldehyde	0-14	caspase-3	Oryctolagus cuniculus	41-50